Nanological stands at the forefront of MedTech innovation, addressing the pressing challenge of sepsis, which affects 50 million people annually. Our detection technique provides a label-free, multiparametric analysis of bacteria in blood within minutes. Integrated with a cloud-based AI platform, Nanological's technology enables bacterial differentiation without the need for previous blood culture, significantly enhancing survival rates.